Clinical Trial Manager at Abata Therapeutics

San Diego, California, United States

Abata Therapeutics Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

Candidates must possess a Bachelor's degree and at least 5 years of hands-on clinical trial experience, preferably in a pharmaceutical or biotech setting, with a combination of CRO and sponsor-side experience being advantageous. Demonstrated experience in conducting first-in-human and complex autoimmune clinical trials, including setup, monitoring, and close-out, is essential. A strong working knowledge of ICH/GCP regulations and proficiency with electronic systems like eTMF, CTMS, and EDC are required. The ideal candidate will exhibit strong critical thinking, a sense of urgency, proactive problem-solving skills, and excellent interpersonal, written, and verbal communication abilities, along with proficiency in MS Office and comfort with technology. Ability to work independently and collaboratively in a team environment is also necessary.

Responsibilities

The Clinical Trial Manager will oversee the strategic implementation and execution of clinical trials from start-up to close-out, managing CROs, study vendors, and clinical trial sites. This role involves ensuring trials are completed on time, within budget, and in accordance with regulatory requirements, GCP guidelines, and internal SOPs. Key duties include preparing and maintaining study files, organizing meetings, coordinating clinical trial equipment and supplies, ensuring team compliance with training, performing TMF reviews, supporting sites for audits, assisting with budget management, tracking subject and site activity, identifying and escalating issues, and contributing to study setup activities such as protocol development and regulatory submissions. The manager will also collaborate with CROs for TMF document collection, coordinate with regulatory affairs, support study close-out activities, and communicate effectively with study team members, while participating in process improvement initiatives.

Skills

Clinical Trial Management
CRO management
Study vendor coordination
Clinical trial site management
GCP/ICH compliance
Regulatory submissions
TMF management and audits
Budgets and cost tracking
CTMS
IRT
Protocol development
Informed Consent Form development
Audit readiness
Data review meetings
Operational documentation
Cross-functional coordination
Autoimmune program experience

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI